Twist Bioscience recently reported fourth-quarter and full-year fiscal 2025 results, highlighting record revenue of US$99.01 million and strong double-digit growth across synthetic biology, biopharma, ...

Delve Bio, a pioneer in metagenomic next-generation sequencing (mNGS) for infectious diseases, today announced presentations demonstrating the clinical impact of using its flagship metagenomic ...

The Texas A&M Board of Regents named Kiril Dimitrov, DVM, Ph.D., director of the Texas A&M Veterinary Medical Diagnostic ...

Genetic manipulation – or gene editing – is a concept that describes altering the genetic material (DNA) of an organism.

OmniAb, Inc. and ArrowMark Partners ("ArrowMark") today announced the signing of a license and services agreement for novel OmniAb-derived antibody discovery programs with Mabtrx Biosciences, a wholly ...

The Global Usher Syndrome Market is estimated to be valued at USD 2.29 Bn in 2025 and is expected to reach USD 3.20 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 4.9% from 2025 to ...

Q3 2025 Earnings Call Transcript November 13, 2025 Bionano Genomics, Inc. beats earnings expectations. Reported EPS is ...

Endeavour Mining reported strong third-quarter results on Thursday, saying it remained on track to meet its 2025 production and cost guidance, supported by higher grades, strong gold prices and ...

Bionano Genomics, Inc. ( BNGO) Q3 2025 Earnings Call November 13, 2025 4:30 PM EST Good day, and welcome to the Bionano Third Quarter 2025 Earnings Conference Call. Today's conference is being ...

In the first quarter against Dallas last month, Engram lined up in the slot, tight to the formation off to quarterback Bo Nix ...

Detailed price information for Bionano Genomics Inc (BNGO-Q) from The Globe and Mail including charting and trades.

Artisan Partners, an investment management company, released its “Artisan Small Cap Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. Global equities continue to ...